5 Most Popular Funds on Morningstar

What funds are you considering adding to your investment portfolio? According to Morningstar data it is a mix of high risk high reward biotech and UK equity income funds

Emma Wall 11 June, 2015 | 2:34PM
Facebook Twitter LinkedIn

Is your investment portfolio perfect? Or could you do with new addition to your fund family? Whether you’re picking potential funds for your pension, ISA or fantasy portfolio always consider the suitability of each product alongside existing investments.

Anyone savvy enough to have invested in 2011 will have turned £10,000 into £39,000

Take the most popular fund on Monringstar.co.uk over the last month for example. Axa Framlington Biotech may have delivered a whopping 45% in 2014, but this type of niche investment should only ever play a supporting role in a well-diversified portfolio. Its concentrated exposure can result in volatile returns – although anyone savvy enough to have invested in 2011 will have turned £10,000 into £39,000 today.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AXA Framlington Biotech R Acc262.40 GBP-0.34Rating
Franklin Biotechnology Discv A(acc)USD43.13 USD0.62Rating
Invesco UK Eq High Inc UK Inc326.59 GBP0.40Rating
LF Equity Income C Sterling Acc3.45 GBP0.00
LF Lindsell Train UK Equity Acc516.60 GBP0.91Rating

About Author

Emma Wall  is former Senior International Editor for Morningstar

© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement